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Contactin-associated protein-like 2 (Caspr2), also known as CNTNAP2, is a cell
adhesion molecule that clusters voltage-gated potassium channels (Kv1.1/1.2) at
the juxtaparanodes of myelinated axons and may regulate axonal excitability. As a
component of the Kv1 complex, Caspr2 has been identified as a target in neuromyotonia
and Morvan syndrome, but also in some cases of autoimmune limbic encephalitis
(LE). How anti-Caspr2 autoimmunity is linked with the central neurological symptoms
is still elusive. In the present study, using anti-Caspr2 antibodies from seven patients
affected by pure LE, we determined that IgGs in the cerebrospinal fluid of four out
seven patients were selectively directed against the N-terminal Discoïdin and LamininG1
modules of Caspr2. Using live immunolabeling of cultured hippocampal neurons, we
determined that serum IgGs in all patients strongly targeted inhibitory interneurons.
Caspr2 was highly detected on GAD65-positive axons that are surrounding the cell
bodies and at the VGAT-positive inhibitory presynaptic contacts. Functional assays
indicated that LE autoantibodies may induce alteration of Gephyrin clusters at inhibitory
synaptic contacts. Next, we generated a Caspr2-Fc chimera to reveal Caspr2 receptors
on hippocampal neurons localized at the somato-dendritic compartment and post-
synapse. Caspr2-Fc binding was strongly increased on TAG-1-transfected neurons
and conversely, Caspr2-Fc did not bind hippocampal neurons from TAG-1-deficient
mice. Our data indicate that Caspr2 may participate as a cell recognition molecule in
the dynamics of inhibitory networks. This study provides new insight into the potential
pathogenic effect of anti-Caspr2 autoantibodies in central hyperexcitability that may be
related with perturbation of inhibitory interneuron activity.
Keywords: CNTNAP2, TAG-1, contactin 2, voltage-gated potassium channels, autoimmunity, interneurons, cell
adhesion
Abbreviations: CAM, cell adhesionmolecule; CIDP, chronic inﬂammatory demyelinating polyneuropathy; DIV, day in vitro;
DRG, dorsal root ganglia; EGF, epidermal growth factor-like; GPI, glycan phosphatidyl inositol; Ig, immunoglobulin; LE,
limbic encephalitis; PDZ, PSD95/Dlg1/Zo-1; VGKC, voltage-gated potassium channels.
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Introduction
Contactin-associated protein-like 2 Caspr2 (also known as
CNTNAP2) is a CAM that belongs to the Neurexin family and is
associated with both neuropsychiatric disorders and autoimmune
diseases. One function of Caspr2 has been well characterized as
a component of the juxtaparanodes of myelinated ﬁbers in the
CNS and PNS (Poliak et al., 2003). Caspr2 extracellular domain
interacts with contactin 2/TAG-1, a glycosyl-phosphatidyl-
inositol anchored Ig-CAM expressed by both axonal and facing
glial membranes (Traka et al., 2003). Caspr2 cytoplasmic tail
contains a binding site for the cytoskeleton adaptor protein 4.1B
and a C-terminal PDZ binding sequence (Horresh et al., 2008).
The Caspr2 complex mediates the clustering of VGKCs, mainly
Kv1.1 and Kv1.2 at juxtaparanodes (Poliak et al., 2003; Traka
et al., 2003). The role attributed to these channels is to stabilize
conduction at the nodes of Ranvier, avoid repetitive ﬁring and
help to maintain the internodal resting potential (Rasband, 1998;
Devaux and Gow, 2008). Knock-out mice for either Caspr2,
TAG-1, or protein 4.1B display diﬀused of Kv1.1/1.2 along
the internode, albeit, the mis-localization of Kv1 channels does
not aﬀect nerve conduction (Poliak et al., 2003; Traka et al.,
2003; Cifuentes-Diaz et al., 2011). Caspr2 also co-localizes with
the Kv1.1/Kv1.2 channels at the axon initial segment and may
regulate axonal excitability at this site (Inda et al., 2006; Ogawa
et al., 2008).
Apart from its well-known function in Kv1 channel clustering
at juxtaparanodes, Caspr2 may also act as a cell recognition
molecule during development and synaptic network formation.
Caspr2-deﬁcient mice show a defect in the migration of
cortical neurons and a reduction in the number of GABAergic
interneurons which are associated with an epileptic phenotype
and autism-related behaviors (Penagarikano et al., 2011). RNAi-
mediated knockdown of Caspr2 aﬀects synaptic organization
and function in culture (Anderson et al., 2012). Mutations of
the Caspr2 gene (cntnap2) have been unambiguously associated
with neuropsychiatric disorders, such as developmental language
impairment and autistic spectrum disorders (Strauss et al., 2006;
Bakkaloglu et al., 2008; Penagarikano and Geschwind, 2012;
Rodenas-Cuadrado et al., 2013). However, the altered neuronal
functions underlying these disorders remain elusive.
Numerous studies have implicated the VGKC-complex as
an autoimmune target in generalized neuromyotonia, persistent
facial myokymia, Morvan’s syndrome, and in LE (Vincent et al.,
2004). Recent studies revealed that in most patients with anti-
VGKC-complex antibodies, the immune targets are in fact
Leucine-rich glioma inactivated 1 (LGI1), a secreted protein
associated with presynaptic Kv1 channels (Lai et al., 2010) or
the juxtaparanodal CAMs, Caspr2 and TAG-1 (Irani et al.,
2010; Lancaster et al., 2011). In the present study, we used
anti-Caspr2 IgGs of patients with pure LE to label cultured
hippocampal neurons and characterize targeted cell types and
subcellular compartments. In addition, we generated a Caspr2-
Fc chimera to analyze the distribution of Caspr2 binding sites
on hippocampal neurons. We showed that Caspr2 is mainly
expressed by inhibitory axons and may participate to trans-
synaptic adhesion complexes. This study provides new insight
into the potential pathogenic eﬀect of anti-Caspr2 autoantibodies
in central hyperexcitability that may be related with perturbation
of inhibitory synaptic transmission.
Materials and Methods
Constructs
The pCDNA3-Caspr2-HA construct encodes human Caspr2
with the HA epitope inserted downstream the signal peptide
between the residues Trp26 and Thr27 (Bel et al., 2009). Caspr2-
mcherry was generated by PCR ampliﬁcation and insertion into
the EcoR1-BamH1 sites of pmCherry-N1 vector. The Caspr2-
HA deleted constructs, Caspr21 (32-361), Caspr22 (362-
600), Caspr23 (600-950), Caspr24 (955–1169) were
generated by QuickChange mutagenesis (Agilent Technologies).
The Caspr2-Discoïdin-LamininG1, Caspr2-Discoïdin, Caspr2-
LamininG1 (Figure 2A) were obtained using reverse PCR
on HA-tagged full length Caspr2 plasmid and the fragment
fusion was performed using the In-Fusion kit (Clontech). The
Caspr2-Fc construct was generated by PCR ampliﬁcation of
Caspr2 extracellular domain (amino acids 1–1242) and insertion
into the Kpn1-Not1 cloning sites of pIg-plus vector. The
human TAG-1-GFP construct was generated by inserting GFP
downstream the signal peptide. PCR ampliﬁed products were
veriﬁed by sequencing (Beckman Coulter Genomics). Plasmids
encoding human LGI1, ADAM22, ADAM23 were purchased
from Origene. Gephyrin-GFP is a kind gift of Dr. F. Ango.
Patient’s Serum and CSF
The presence of anti-Caspr2 autoantibodies was assessed using
the patient’s cerebrospinal ﬂuid (CSF) as previously described
(Viaccoz et al., 2014). Patients were considered positive when
positive staining of a cell-based assay with human embryonic
kidney cells (HEK-293) cells overexpressing the Caspr2 protein
was observed. After the identiﬁcation of anti-Caspr2 antibodies
by the French PNS Reference Center, serum and CSF samples
were frozen and conserved at −80◦C. A written consent was
obtained from all patients, and the use of samples for this study
was approved by the institutional review board of the University
Claude Bernard Lyon 1/Hospices Civils de Lyon. The patient’s
clinical data were prospectively collected at least twice a year by
phone or mail.
Antibodies and Immunofluorescence Staining
The IgGs from patients’ sera were puriﬁed using the Melon
gel kit (Pierce). Rabbit anti-Caspr and rat anti-Gliomedin
were described previously (Labasque et al., 2011), rabbit anti-
MAP2 was a gift from Dr. J. F. Leterrier, rabbit anti-AnkyrinG
from Dr. G. Alcaraz, and rabbit anti-vGLUT1 from Dr. S. El
Mestikawy. The mouse anti-GAD65 mAb was obtained from
Developmental Studies Hybridoma Bank, University of Iowa and
anti-Kv1.2 (clone K14/16) mAb from UC Davis/NIH NeuroMab
Facility, UCDavis, mouse anti-tau mAb was purchased from
Sigma, mouse anti-Synaptophysin mAb from Chemicon, guinea-
pig anti-VGAT from Synaptic Systems and rat anti-HA mAb
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was purchased from Roche. AlexaFluor488-, 568-, and 647-
conjugated secondary antibodies were obtained from Molecular
Probes. Immunostaining with IgGs from LE patients was
performed on live cells diluted 1:500 in culture medium
for 30–60 min. Cells were ﬁxed with 4% paraformaldehyde
in PBS for 10 min and permeabilized with 0.1% Triton-
X100 for 10 min. Immunoﬂuorescence staining was performed
using rabbit anti-MAP2 (1:2000), rabbit anti-vGLUT1 (1:100),
rabbit anti-AnkyrinG (1:500), or guinea-pig anti-VGAT (1:400)
antibodies, or mouse anti-tau (1:500), anti-Kv1.2 (1:500), anti-
GAD65 (1:200), or anti-Synaptophysin (1:200) mAbs, and with
secondary antibodies diluted in PBS containing 3% bovine serum
albumin. After washing in PBS, cells were mounted in Mowiol
(Calbiochem).
Flow Cytometry and Isotyping
HEK-293 cells were transfected with Caspr2-HA, harvested
and double-labeled using anti-HA mAb and IgGs from LE
patients and secondary antibodies conjugated with FITC or
Phycoerythrin (Beckman Coulter). FITC-conjugated anti-human
IgG1, IgG2, IgG3, and IgG4 were purchased from Bindingsite.
Cells were washed and ﬁxed with 2% paraformaldehyde and
analyzed on FACSCanto with the CellQuest software (Becton
Dickinson).
Cell Culture
Cell culture media and reagents were from Invitrogen.
Neuroblastoma N2a cells and HEK-293 cells were grown in
DMEM containing 10% fetal calf serum and were transiently
transfected using jet PEI (Polyplus transfection, Ozyme).
Caspr2-Fc, control and deletion mutants were produced in
the supernatant of transfected HEK-293 cells and aﬃnity
puriﬁed using Protein-A Sepharose. Transfected N2a cells and
hippocampal neurons were incubated with Caspr2-Fc (10µg/ml)
pre-clustered with Alexa488 or 568 conjugated anti-human Fc
(50 µg/ml) for 30 min at 37◦C. Primary hippocampal cell
cultures were performed from embryonic day 18-Wistar rats.
Hippocampi were collected in Hanks’ balanced salt solution,
dissociated with trypsin and plated at a density of 1.2.105
cells/cm2 on poly L-lysine coated coverslips. The hippocampal
neurons were cultured in Neurobasal supplemented with
2% B-27, 1% penicillin-streptomycin, and 0.3% glutamine
in a humidiﬁed atmosphere containing 5% CO2 at 37◦C.
Hippocampal neurons were transfected using Lipofectamine
2000 with Gephyrin-GFP or GFP at DIV 14, or with TAG-1-GFP,
LGI1-GFP, ADAM22, and ADAM23 at DIV8. Hippocampal cell
cultures were prepared from embryonic day 16 C57BL6wild-type
and Tag-1−/− mice (Traka et al., 2003) with the same protocol.
For functional perturbing assays, DIV17 neurons transfected
with Gephyrin-GFP were incubated for 1 h at 37◦c with culture
medium, control, LE5 or LE6 IgGs using 1/100 dilution in
100 µl volume before ﬁxation and immunostaining for GAD65.
Experiments were performed in duplicate and four coverslips
analyzed under each condition. All animal experiments were
carried out according to the animal care and experimentation
committee rules approved by CNRS.
Confocal Microscopy and Image Analysis
Image acquisition was performed on a Zeiss laser-scanning
microscope equipped with 63× 1.32NA oil-immersion objective.
Images of GFP or AlexaFluor-stained cells were obtained using
the 488 nm band of an Argon laser and the 568 and 647 nm
bands of a solid state laser for excitation. Fluorescence images
were collected automatically with an average of two-frame
scans and collected as frame-by-frame sequential series for tiles.
To quantify the number of inhibitory pre-synaptic contacts
immunostained for Caspr2, we estimated the number of GAD65
clusters that were positive or negative for Caspr2 along 25 µm-
dendrite lengths (n = 14 neurons). To quantify the number
of post-synaptic contacts labeled for Caspr2-Fc, we estimated
the number of Synaptophysin clusters contacting the shaft and
spines that were positive or negative for Caspr2-Fc along 50 µm-
dendrite lengths (n = 21 dendrites, 7 neurons) using the
image-J software. To quantify the number of synaptic and total
Gephyrin-GFP clusters per neuron, we used Imaris as software
(BitplaneAG, Switzerland) with automatic detection of objects
in 3-dimensional space using six z-stack projections. The “spot”
tool of surpass function was used to detect the GAD65 pre-
synaptic clusters and post-synaptic Gephyrin-GFP clusters and
the same segmentation threshold was used for all the images
in each channel. The intracellular aggregates of Gephyrin-GFP
(spot diameter >0.6 µm) were removed. We selected the post-
synaptic spots opposed to pre-synaptic spots within a 0.6 µm
distance with the “co-localize spots” option. The ratio of synaptic
relative to total Gephyrin clusters and the number of synaptic
Gephyrin clusters per neuron were determined under each
condition. The total number GAD65 clusters contacting the
somato-dendritic compartment was determined using the “find
spots close to surface” tool. To analyze the eﬀect of incubation with
control and LE IgGs, data were pooled from two independent
cultures (four coverslips, n= 23–36 neurons analyzed under each
condition) and signiﬁcant diﬀerences were determined using
ANOVA followed by Fisher’s test.
Results
Autoantibodies to Caspr2 in LE Bind
Hippocampal Neurons in Culture
We identiﬁed Caspr2 as a target antigen in a series of seven
patients with LE. The clinical features in Table 1 indicate
that these patients showed pure LE characterized by confusion,
amnesia, and seizures, without neuromyotonia. All the sera
(named LE1-LE7) were reactive for dendrotoxin-precipitated
VGKC as analyzed using radio-immunoassays, negative for LGI1
and reacted against Caspr2 at high titer as assayed using cell
binding assays and ﬂow cytometry (Table 1).
As shown for patients LE1-4, these autoantibodies strongly
labeled Caspr2-transfected N2a cells (Figure 1A). Since Caspr2
is a component of the juxtaparanodal VGKC complex, the serum
IgGs of patients with LE were tested on teased mouse sciatic
nerves. We determined that the serum IgGs of patients bound
juxtaparanodes after methanol ﬁxation as shown for LE1, LE6,
and LE7 (Figure 1B). Next, we showed that the serum IgGs
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TABLE 1 | Basic epidemiological, immunological, and clinical features of LE patients with antibodies against Caspr2.
Patient Age (gender) Titers Clinical features Treatment with improvement
LEI 73 (M) 1/51,200 limbic encephalitis, confusion, seizures, prostate cancer IVIg
LE2 62 (M) 1/12,800 limbic encephalitis, confusion, temporal seizures, prostate cancer IVIg
LE3 60 (M) 1/6,400 memory disturbances, thyroid cancer with metastasis plasmapheresis
LE4 71 (M) 1/51,200 memory disturbances, temporal seizures corticosteroids, mycophenolate, mofetil
LE5 64 (M) 1/51,200 limbic encephalitis, confusion, ataxia, seizures corticosteroids
LE6 60 (M) 1/51,200 limbic encephalitis, confusion, amnesia, sub-clinical seizures corticosteroids
LE7 72 (M) 1/12,800 limbic encephalitis, confusion, amnesia, seizures corticosteroids, anti-convulsant
These patients did not present neuromyotonia. The titer of serum IgGs was determined using flow cytometry.
of all patients bound rat hippocampal neurons in culture using
live immunostaining (Figure 1; Supplementary Figure S1).
We showed that immunostaining with LE1–LE5 serum IgGs
was abolished by pre-adsorption on HEK cells transfected with
Caspr2 (Figure 1G and Supplementary Figures S1B,D,F,H).
These data indicate that the IgGs from these patients recognized
only Caspr2 in cultured hippocampal neurons.
Previous studies using rabbit anti-Caspr2 antibodies directed
against the cytoplasmic region of the molecule, showed
that Caspr2 is expressed at low level in axons of cultured
hippocampal neurons (Ogawa et al., 2008; Bel et al., 2009)
when compared with juxtaparanodes of myelinated axons (Traka
et al., 2003). Using anti-Caspr2 LE1 IgGs, we observed surface
labeling of the somato-dendritic and axonal compartments of
DIV4 neurons double-stained for MAP2 and tau, respectively,
(Figures 1C,D,D’). At DIV7, a punctate staining of neurites
was detected. Double-staining for MAP2 indicated that Caspr2
was faintly expressed at the surface of the somato-dendritic
compartment at that stage (Figures 1E,F,F’). In contrast,
Caspr2 strongly colocalized with the axonal marker tau. Only
a subpopulation of axons was immunostained (Figure 1F,
arrows) whereas some axons were unlabeled (Figures 1F,F’,
arrowheads). This preferential distribution of Caspr2 at the
axonal surface of hippocampal neurons was also observed
using live immunostaining with LE2–LE5 serum IgGs at DIV7
(Supplementary Figures S1A,C,E,G).
As Caspr2 is known to be associated with Kv1.1/1.2 channels at
juxtaparanodes of myelinated ﬁbers and at axon initial segments
in various neuronal cell types such as motoneurons or cortical
pyramidal cells (Inda et al., 2006; Duﬂocq et al., 2011), we tested
for a possible co-localization in cultured hippocampal neurons.
As shown using LE1 serum IgGs in Figures 1H,H’ surface
staining for Caspr2 was observed along the axon but was not
enriched at the axon initial segment, which was strongly stained
for Kv1.2 and AnkyrinG at DIV14.
The N-Terminal Modules of Caspr2 Can be
Selectively Targeted by Autoantibodies in LE
Patients
Recent studies pointed to the importance of the IgG4 subtype in
autoimmune neurological diseases such as myasthenia gravis and
CIDP (Huijbers et al., 2013; Labasque et al., 2014; Querol et al.,
2014). Using ﬂow cytometry, we studied the IgG speciﬁcities of
our samples and determined that anti-Caspr2 IgG4 were present
in all the LE patients. In addition, IgG4 was the predominant
isotype in four out of seven patient’s sera (Table 2). The IgG4
do not mediate complement activation, nor bind Fc receptors on
eﬀector cells. This could be an indication that the IgG4 in the CSF
of LE patients may be pathogenic via functional blocking activity.
Next, to determine if IgGs of LE patients with anti-Caspr2
autoimmunity may recognize speciﬁc modules of Caspr2, we
generated Caspr2 constructs encompassing sequential deletions
1, 2, 3, and 4 of the protein (Figure 2A). Flow
cytometry and cell based assays were performed on HEK
cells expressing Caspr2 constructs (Figure 2B). All patients’
sera recognized the Caspr2-2, 3, and 4 constructs. On
the opposite, three sera and four CSF out of seven did not
recognize Caspr2-1 (Figure 2C; Table 2). Thus, the N-terminal
Discoïdin and LamininG1 domains could be a major epitope in
patients with LE. To precisely map the epitopes, we generated
additional constructs, Caspr2-Discoïdin-LamininG1, Caspr2-
Discoïdin, and Caspr2-LamininG1 as depicted in Figure 2A and
showed that all the seven sera and CSF tested recognized both
the Discoïdin and LamininG1 modules, whereas the 30 amino-
acids linker between these two modules was not recognized. The
speciﬁc function of this N-terminal region is still unknown.
GABAergic Neurons are the Main Target of
Anti-Caspr2 Autoantibodies in Patients with LE
Since only a subpopulation of axons was labeled using anti-
Caspr2 LE1 serum IgGs, we further investigated whether
excitatory or inhibitory subpopulation of neurons may be
diﬀerentially targeted. DIV4 neurons were analyzed to study
the somato-dendritic expression of Caspr2 at early stage. We
ﬁrst determined that 22% of MAP2-positive neurons were
GABAergic using glutamate decarboxylase GAD65 as a marker
(Figures 3A,B). Next using immunolabeling with LE1 serum
IgGs, we estimated that 58% of the inhibitory neurons in
contrast to only 4% of excitatory neurons (negative for GAD65,
arrows) expressed Caspr2 at DIV4 (Figures 3A,B; Table 3).
Thus, most of the Caspr2-positive neurons (81%) were inhibitory
neurons as illustrated in Figure 3C. In the same manner,
quantitative analyses were performed using LE2–LE5 serum IgGs
and indicated that 51–68% of GAD65-positive neurons and only
4–8% of GAD65-negative neurons were targeted by these patients
IgGs (Table 3).
We also examined how Caspr2 was distributed along axons
and pre-synaptic sites at DIV14 and DIV21 later stages. The
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FIGURE 1 | Limbic encephalitis autoantibodies directed against Caspr2
bind hippocampal neurons in culture. (A) Neuroblastoma N2a cells were
transfected with Caspr2-mcherry (red) and surface labeled with IgGs from
LE1–LE4 patients (green). (B) Teased sciatic nerve of adult mice were fixed with
methanol and immunostained for Contactin-associated protein Caspr (blue) and
AnkyrinG (AnkG) (green) as markers of the paranodal and nodal regions of the
nodes of Ranvier, respectively. Note that autoantibodies of patients LE1, LE6
and LE7 bound the juxtaparanodes (red). (C–H) Rat hippocampal neurons at
DIV4 (C,D,D’), DIV7 (E–G), and DIV14 (H,H’) were surface labeled with LE1
IgGs (red). Cells were fixed with 4% paraformaldehyde, permeabilized, and
double-stained for the somato-dendritic marker MAP2 (green in C,E,G; blue in
F’) or axonal tau (green in D,F). Caspr2 surface staining was detected on the
somato-dendritic and axonal compartments at DIV4 (C,D,D’) but was mainly
associated with axonal processes at DIV7 (E,F,F’). In (F), yellow arrows indicate
axons that were double-stained for Caspr2 and tau, whereas white arrowheads
indicate unlabeled tau-positive axons. (G) LE1 IgGs were pre-adsorbed using
incubation with Caspr2-transfected HEK cells and did not bind hippocampal
neurons. (H,H’) Hippocampal neurons at DIV14 were surface labeled for Caspr2
using LE1 IgGs (red) and fixed and permeabilized before immunostaining with
mouse-anti-Kv1.2 mAb (green) and rabbit anti-AnkyrinG antibodies (blue). The
Kv1.2 channels were enriched at the axonal initial segment stained for AnkyrinG,
whereas surface Caspr2 was distributed along the axon. Insets are twofold
magnification images. Fluorescence microscopy (A) and confocal images
(B–H). Bar is in (A), 20 µm; in (B), 5 µm; in C–G, 15 µm; in (H,H’), 30 µm.
vesicular glutamate transporter-1 vGLUT1 was used as a marker
for glutamatergic axons and synapses. As shown in Figure 4A,
some of the vGLUT1-positive axons at DIV14 were labeled
for Caspr2 using LE1 serum IgGs. High magniﬁcation images
show that Caspr2 co-localized with vGLUT1 at pre-synaptic
sites (Figure 4A’, arrowheads). Next we used GAD65, which
synthesizes GABA for neurotransmission as a marker for
inhibitory axons and synapses. Caspr2 strongly co-localized with
GAD65-positive axons as observed using serum IgGs of all
the patients analyzed (Supplementary Figure S2). In particular,
the GAD65-positive axons were surrounding the MAP2-labeled
large pyramidal neurons and were heavily stained for Caspr2
at DIV14 and DIV21 as shown using LE1 serum IgGs (arrows
in Figures 4B,C). The presynaptic sites labeled for GAD65
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TABLE 2 | Isotyping and domain mapping of serum and CSF IgGs from LE
patients using flow cytometry and cell binding assays.
Patient Serum CSF
Isotypes Domain
mapping
Isotypes Domain
mapping
LEI IgGl, IgG2 > IgG3,
IgG4
Multiple IgGl, IgG4 Multiple
LE2 IgGl > IgG4 Multiple IgGl > IgG4 Multiple
LE3 IgG4 Discoidin-
LNGl
IgG4 Discoidin-
LNGl
LE4 IgG2 > IgGl, IgG4 Multiple IgGl Discoidin-
LNGl
LE5 IgG4 > IgGl Multiple IgG4 > IgGl Multiple
LE6 IgG4 Discoidin-
LNGl
IgG4 Discoidin-
LNGl
LE7 IgG4 > IgGl Discoidin-
LNGl
IgGl, IgG4 Discoidin-
LNGl
HEK cells were transfected with full-length or 1-, 2-, 3-, and 4-deleted
Caspr2 constructs and were surface-labeled for the HA epitope. Sera at 1:500
dilution were analyzed for IgG1–IgG4 isotypes and CSF at 1:20 dilution for IgG1
and IgG4.
were intensely stained for Caspr2 at the contact with the
soma (arrowheads in Figure 4C”) or dendrites (arrowheads
in Figures 4B’,C”’). We estimated that 51% of the GABAergic
pre-synaptic contacts on dendrites were labeled for Caspr2
(5.9 ± 0.5 Caspr2-positive of 11.6 ± 0.5 total GABAergic
contacts/25 µmdendritic length; n= 14 dendrites). As illustrated
in Figure 4C’, Caspr2 was distributed along inhibitory axons
partially overlapping with GAD65 puncta. We estimated that
34 % of the Caspr2-positive clusters contacting dendrites were
GAD65-positive (13.7± 2 Caspr2-positive clusters among which
4.7 ± 0.8 were GABAergic/25 µm).
Hippocampal neurons were transfected at DIV14 with
Gephyrin-GFP to visualize the post-synaptic clusters facing pre-
synaptic inhibitory contacts at DIV21 (Figure 5A). Gephyrin is
the major post-synaptic scaﬀolding protein at inhibitory synapses
(Craig et al., 1996). As shown in Figure 5A’, pre-synaptic
terminals positive for both GAD65 and Caspr2 were apposed
to Gephyrin-GFP clusters (arrowheads). In addition, surface
Caspr2 colocalized with the inhibitory presynaptic terminals
that were labeled for VGAT (Figures 5E,E’). We asked whether
the LE patient’s autoantibodies directed against Caspr2 could
display functional blocking activity by destabilizing inhibitory
synaptic contacts. The LE5 and LE6 autoantibodies were tested
which are mainly of the IgG4 isotype. LE5 IgGs are directed
against multiple domains of Caspr2 and LE6 IgGs only target
the N-terminal modules. Hippocampal neurons were transfected
with Gephyrin-GFP at DIV14 and incubated at DIV17 with
the culture medium, control IgGs, LE5, or LE6 IgGs diluted
1:100 for 1 h at 37◦C. Using automatic spot detection of
the Imaris software, we determined under each condition the
number of total Gephyrin-GFP clusters and the number of
Gephyrin-GFP clusters apposed to GAD65-positive presynaptic
terminals (Figure 5B, white arrows). The ratio of synaptic versus
total Gephyrin-GFP clusters was not signiﬁcantly aﬀected by
incubation during 1 h with LE autoantibodies (Figure 5C).
However, a signiﬁcant decrease in the number of synaptic
Gephyrin clusters per neuron was observed for LE5 and LE6
(24.5 and 30%, respectively, P < 0.05 using ANOVA and
Fisher’s test) but not for control IgGs (10%) by comparison with
culture medium incubation (Figure 5D). The number of GAD65-
positive clusters contacting the somato-dendritic compartment
per Gephyrin-GFP transfected neuron was not signiﬁcantly
decreased (284 ± 41 with culture medium, 230 ± 18 with control
IgGs, 218 ± 21 with LE5, 210 ± 30 with LE6). Since Caspr2
was only expressed in 60% of GAD65-positive neurons, the
functional eﬀect of LE autoantibodies may be underestimated. In
conclusion, we observed that Caspr2 is selectively localized along
GABAergic axons and at the inhibitory pre-synaptic terminals
in cultured hippocampal neurons. In addition, the perturbating
assays of post-synaptic Gephyrin clusters suggest that anti-
Caspr2 autoantibodies of LE patients may be pathogenic by
altering the inhibitory synaptic contacts.
The Caspr2-Fc Binding Sites are Localized on
the Somato-Dendritic Compartment
Caspr2 belongs to the family of neurexins, which are pre-
synaptic CAMs. Studies in culture indicate that neurexins are
implicated in synaptogenesis by inducing the clustering of
post-synaptic neuroligins (Dean et al., 2003; Craig and Kang,
2007). Neurexin/neuroligin association promotes the formation
of excitatory and inhibitory synapses by interacting with PSD95
or Gephyrin, respectively. We asked whether Caspr2 might
be also involved in trans-synaptic contacts. With this aim,
we generated a Caspr2-Fc chimera to detect Caspr2 binding
sites in hippocampal neuronal culture. Caspr2-Fc plasmid
was transfected in HEK cells and the recombinant protein
puriﬁed from the culture supernatant using Protein A-aﬃnity
chromatography. The chimera pre-clustered with ﬂuorescent
anti-Fc IgG was incubated with hippocampal neurons at DIV4
(Figure 6). We observed that Caspr2 binding sites were present
on both GAD65-negative (arrow in Figure 6A) and GAD65-
positive neurons (green arrow in Figure 6B). Quantitative
analysis indicated that Caspr2-Fc bound 36% of the total
neurons (Figure 6C). Caspr2-Fc bound to the somato-dendritic
compartment of DIV7 neurons as determined using double-
staining for MAP2 (Figures 6D,D’). In contrast, Caspr2-Fc was
not co-localized with axons immunostained with anti-tau mAb
(Figures 6E,E’). Caspr2-Fc binding sites were distributed on the
somato-dendritic compartment of both inhibitory (26± 6%) and
excitatory (38 ± 5%) neurons as analyzed at DIV4 (n = 504
neurons, three coverslips; Figure 6C).
Next, we analyzed whether the Caspr2 binding sites may be
distributed at the post-synaptic sites. Neurons were transfected
with GFP at DIV14 to clearly visualize dendrites and spines of
isolated neurons at DIV21 (Figure 7A). Synaptic contacts on
dendritic shafts (arrowheads) or spines (arrow) were detected
using Synaptophysin as a pre-synaptic marker. As shown in
high magniﬁcation pictures, Caspr2 binding sites (red) were
detected on shafts at the contact with the pre-synaptic marker
(blue; Figures 7A’,A”). Quantitative analysis indicated that 58%
of post-synapses on shafts and 48% on spines were labeled
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FIGURE 2 | Epitope mapping of anti-Caspr2 autoantibodies in LE
patients. (A) Caspr2-HA constructs encompassing sequential deletions:
1 deleted of the N-terminal discoïdin and Laminin-G1 domains, 2
deleted of the Laminin-G2 and EGF-like1 domains, 3 deleted of the
central fibrinogen and Laminin-G3 domains, 4 deleted of the
EGF-like2, and Laminin-G4 domains, Caspr2-Disc-LNG1, Caspr2-Disc,
and Caspr2-LNG1 only including the Discoïdin and/or LamininG1
modules in the ectodomain. (B) Flow cytometry analysis of anti-Caspr2
IgG titer of LE1 serum. Untransfected and Caspr2-HA-transfected HEK
cells were incubated with serial dilutions of LE1 serum
(1/3,200–1/51,200) and phycoerythrin-conjugated anti-human IgG
(Anti-IgG-PE). (C) Flow cytometry analysis of anti-Caspr2 serum IgGs
of LE1 and LE6 on HEK cells transfected with full-length or 1
deleted Caspr2-HA construct.
with Caspr2-Fc chimera (n = 21 images; Figure 7B). Thus, the
receptors of Caspr2 were present both at inhibitory and excitatory
post-synaptic sites on shafts and spines, respectively. The Caspr2-
binding sites at the inhibitory post-synapses were complementary
to the distribution of Caspr2 at inhibitory pre-synaptic sites.
The Somato-Dendritic Binding Sites of Caspr2
Depends on TAG-1 but not on LGI1, ADAM22,
and ADAM23
Contactin 2/TAG-1 is an Ig-CAM that associates with Caspr2
and the VGKC complex at juxtaparanodes (Poliak et al., 2003;
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FIGURE 3 | GAD65-positive neurons are the main target of anti-Caspr2
LE1 autoantibodies. DIV4 hippocampal neurons were surface labeled with
LE1 IgGs (red), fixed and permeabilized before immunostaining for MAP2 (blue)
as a neuronal marker and GAD65 (green) to identify inhibitory neurons. (A) Low
magnification image showing neurons that were surface labeled for Caspr2
(red). Most of them were GAD65-positive (green, arrowheads) and few were
GAD65-negative (arrows). The box enlarged in C shows GAD65-positive
neurons in green that were surface labeled for Caspr2. The arrowhead points to
an isolated inhibitory neuron strongly labeled for Caspr2 on the soma
(B) Quantitative analysis of the percentage of total neurons, GAD65-positive and
GAD65-negative neurons that were surface labeled for Caspr2. Means ± SEM
of three independent experiments. (A) Tiling of 5 × 4 confocal images acquired
with the 63x objective, z-stack of 6 confocal sections with z-step of 0.5 µm. Bar
is in A, 80 µm; in (C), 35 µm.
TABLE 3 | The anti-Caspr2 autoantibodies in LE patients target inhibitory neurons.
% Caspr2-positive neurons
(n) % inhibitory neurons GAD65-positive Total MAP2-positive Inhibitory GAD65-positive Excitatory GAD65-negative
LEI 434 22 ± 1 16 ± 3 58 ± 5 4 ± 2
LE2 480 17.4 ± 4 15 ± 3.8 51.2 ± 3.7 7.2 ± 3.7
LE3 374 23.9 ± 1 18.9 ± 4.5 57.4 ± 8.9 6.7 ± 3.2
LE4 354 19.9 ± 3.5 19.1 ± 3.9 64.3 ± 4.8 8.3 ± 3.3
LE5 358 21.5 ± 1.2 19.9 ± 2.7 68.5 ± 8.2 6.5 ± 1.2
After four days in vitro hippocampal neurons were surface labeled with LE1–LE5 IgGs and double-stained for MAP2 as a neuronal marker and GAD65 to identify inhibitory
neurons. (n) indicates the total number of neurons analyzed on three different coverslips.
Traka et al., 2003). It was previously reported that TAG-
1 strongly associates in cis with Caspr2 whereas the trans-
interaction remains elusive, since TAG-1-Fc does not bind to
Caspr2 expressed at the cell membrane of HEK cells (Traka
et al., 2003). Conversely, we observed that the pre-clustered
Caspr2-Fc chimera bound N2a cells transfected with GPI-
anchored TAG-1 fused with GFP downstream the signal peptide
(Figure 8A). In addition, Caspr2-Fc binding was strongly
enhanced on neurons transfected with TAG-1 when compared
with untransfected neurons (Figures 8B,C), indicating that the
trans-interaction with TAG-1 strongly occurs in neuronal cells.
Next, we tested whether Caspr2-Fc bound on hippocampal
neurons from Tag-1−/− mice. Caspr2-Fc binding was faintly
detected on TAG-1-deﬁcient neurons (Figure 8D). In contrast,
Caspr2-Fc strongly labeled hippocampal neurons from Tag-1−/−
mice that were transfected with TAG-1-GFP in contrast with
untransfected neurons (Figure 8E).
We also tested whether the binding of Caspr2-Fc may depend
on LGI1/ADAM22 that are members of the VGKC complex and
are recruited at the post-synapse (Fukata et al., 2006; Owuor
et al., 2009; Ogawa et al., 2010). We did not observe any binding
of Caspr2-Fc on N2a cells transfected with LGI1 alone or co-
transfected with LGI1 andADAM22 or ADAM23 (not shown). In
addition, Caspr2-Fc binding was not increased on hippocampal
neurons transfected with LGI1 and ADAM22 or ADAM23 by
comparison with untransfected neurons (Figures 8F,G).
To analyze the subcellular targeting of transfected TAG-1,
neurons were double-transfected with TAG-1-GFP and mCherry
to visualize the dendritic arborisation (Figures 8H,H’). Using
live immunostaining with anti-GFP antibodies, we observed that
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FIGURE 4 | Distribution of Caspr2 at pre-synaptic sites of excitatory and
inhibitory axons. Confocal images of hippocampal neurons at DIV14 (A,B) or
DIV21 (C) that were surface labeled for Caspr2 using LE1 IgGs (red). Cells were
fixed and permeabilized before double-staining for MAP2 (blue), vGLUT1
(A, green) or GAD65 (B,C, green). (A’) Enlarged areas shows glutamatergic
pre-synaptic sites stained for Caspr2. (B’,C’–C”’) Inhibitory pre-synaptic sites
labeled for GAD65 (arrowheads) were intensely stained for Caspr2 at the
contact with the soma (C”) or dendrites (B’,C”’). Note that GAD65-positive
axons surrounding the soma of pyramidal neurons were heavily stained for
Caspr2 (yellow arrows). (C’) This enlarged area shows Caspr2 punctate
immunostaining along a GAD65-positive axon apposed to a dendrite. Bar is in
(A–C), 9 µm; in insets, 1.5 µm.
TAG-1 was addressed to the surface of dendritic arborisation
including at the dendritic spines at DIV17. TAG-1-GFP clusters
were facing presynaptic sites labeled for synaptophysin both
on shafts and spines (Figures 8H,H’, respectively). These data
indicated that transfected TAG-1 was detected post-synaptically
as observed for Caspr2-Fc binding sites. We concluded that
TAG-1 may be critically required for Caspr2-Fc binding on the
post-synaptic compartment of hippocampal neurons.
Discussion
In the present study, we analyzed autoantibodies against Caspr2
in a series of patients with LE. First, we determined that
IgGs in the CSF of four out seven patients selectively react
against the Discoïdin and LamininG1 N-terminal modules of
Caspr2. Second, using live staining of hippocampal neurons
in culture, we showed that autoimmunity to Caspr2 mainly
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FIGURE 5 | (A) Neurons were transfected with Gephyrin-GFP (Geph-GFP,
green) at DIV14 and labeled at DIV21 for surface Caspr2 (red) and GAD65
(blue). (A’) The insets show the pre-synaptic sites double-labeled for
Caspr2 and GAD65 facing post-synaptic clusters of Gephyrin-GFP
(arrowheads). (B) Hippocampal neurons were transfected with
Gephyrin-GFP (green) at DIV14 and incubated at DIV17 with control, LE5
or LE6 IgGs (1/100 dilution) for 1 h at 37◦C. Clusters of post-synaptic
Gephyrin in contact with presynaptic GAD65 are indicated with white
arrows and non-synaptic Gephyrin with red arrows. (C) Quantitative analysis
of the ratio of synaptic relative to total Gephyrin clusters under the different
experimental conditions: incubation with culture medium (CTL), or with
control, LE5 or LE6 IgGs. (D) Number of synaptic Gephyrin-GFP clusters
per neuron. Means ± SEM, n indicates the number of neurons analyzed.
∗ indicates significant difference (P < 0.05) with the culture medium
condition using ANOVA followed by Fischer’s test. (E) Double-staining for
surface Caspr2 (red) and VGAT as a marker of inhibitory pre-synaptic
terminals with the box enlarged in (E’). Note the colocalisation of Caspr2
and VGAT indicated with arrowheads. (A,A’, B,E): Z-stack of five confocal
sections with z-step of 0.5 µm. (E’) is a single confocal section. Bar is in
(A,B,E), 10 µm; in insets (A’,E’), 1.5 µm.
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FIGURE 6 | The binding sites of Caspr2-Fc are localized on the
somato-dendritic compartment. Hippocampal neurons at DIV4 (A–C) and
DIV7 (D,E) were incubated with 10 µg/ml Caspr2-Fc preclustered with
Alexa-conjugated anti-Fc IgGs for 30 min at 37◦C. (A,B) DIV4 neurons bound
with Caspr2-Fc (red). Cells were fixed and permeabilized before double-staining
for MAP2 (blue) and GAD65 (green). (A,B) show representative images of
GAD65-negative neurons (white arrow, A) and GAD65-positive neurons (green
arrow, B) labeled with Caspr2-Fc. (C) Quantitative analysis of the percentage of
total neurons, GAD65-positive and GAD65-negative neurons that were surface
labeled for Caspr2-Fc. Means ± SEM of three independent experiments,
n = 504 neurons. (D,E) DIV7 neurons bound with Caspr2-Fc (green) were
double-stained for MAP2 (D, blue) or tau (E, red). The insets in (D’,E’) show that
Caspr2-Fc preferentially bound on MAP2-positive dendrites and not on
tau-positive axons. (A,B) z-stacks of six confocal sections with z-step of
0.5 µm. (D,E) Single optical sections of confocal images. Bar is in (A,B),
20 µm; in (D,E), 10 µm; in insets, 7 µm.
targets hippocampal inhibitory interneurons (Figure 9A). Anti-
Caspr2 IgGs label GAD65-positive pre-synaptic sites apposed
to Gephyrin post-synaptic clusters. Functional assays indicated
that LE autoantibodies may induce alteration of inhibitory
synaptic contacts. Third, we used a Caspr2-Fc chimera to reveal
Caspr2 receptors on hippocampal neurons. Caspr2 binding sites
are distributed on the somato-dendritic compartment at post-
synaptic sites. We showed that TAG-1 expression is essential for
Caspr2-Fc binding on hippocampal neurons (Figure 9B). These
results indicate that Caspr2 may participate as a cell recognition
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FIGURE 7 | The Caspr2-Fc binding sites are localized at post-synaptic
contacts. (A) Hippocampal neurons were transfected at DIV14 with GFP and
incubated at DIV21 with preclustered Caspr2-Fc (red). Cells were fixed,
permeabilized and immunostained for Synaptophysin (blue). (A’,A”) Insets
show the distribution of Caspr2-Fc binding sites (red) on the dendritic shaft
(arrowheads) or on spines (arrow) that were contacting Synaptophysin
pre-synaptic sites (blue). The green channel is turned down in (A”) to visualize
Synaptophysin clusters. (B) Quantitative analysis of the number of
post-synaptic sites bound with Caspr2-Fc on spines and shaft.
Means ± SEM, n = 21 dendrites of seven neurons. Single confocal sections.
Bar is in (A,B), 20 µm; in insets, 4 µm.
molecule in the dynamics of inhibitory networks. In addition,
they point out to the immune targeting of inhibitory synapses as
a critical clue for understanding the physiopathological role of
Caspr2.
Distinct Axonal Distributions of Caspr2 and
Kv1 Channels in Hippocampal Neurons
We previously reported that transfected Caspr2 is preferentially
addressed to the axon and strongly internalized in the somato-
dendritic compartment in cultured hippocampal neurons at
DIV7 (Bel et al., 2009). The surface expression of Caspr2 is
controlled via a Protein Kinase C-regulated motif of endocytosis
in its cytoplasmic tail (Bel et al., 2009) that might also interfere
with availability of the VGKC-complexes. In the present study,
we used anti-Caspr2 IgGs of LE patients, which display very high
titer, to label endogenous Caspr2. We showed that Caspr2 is
preferentially expressed at the axonal surface, but not enriched
at the axon initial segment as observed for Kv1 channels and
contactin 2/TAG-1 at DIV14. The Kv1.1/1.2 channels display
axonal distribution and are tethered at the axon initial segments
in pyramidal cortical neurons and also in inhibitory neurons in
hippocampal cell culture and slices (Sanchez-Ponce et al., 2012;
Campanac et al., 2013). The recruitment of Caspr2 at the initial
segment might be regulated or its antigenicity masked when
associated with the VGKC complex. However, we showed that
anti-Caspr2 IgGs of several patients bound to VGKC complex at
juxtaparanodes of myelinated axons in culture and were reactive
for dendrotoxin-precipitated VGKC.
Caspr2 is a Pre-Synaptic CAM
Trans-Interacting with TAG-1
Caspr2 functional role may be partly independent from its
association with the VGKC-complexes. Indeed, Caspr2 may
participate in cell adhesive processes and play a morphogenetic
role in neurite outgrowth and synaptogenesis (Anderson et al.,
2012). The phenotypic analysis of Caspr2 knockout mice points
to its involvement in the migration of cortical neurons and
generation or positioning of interneurons (Penagarikano et al.,
2011). The number of parvalbumin-positive interneurons is
reduced in Caspr2 mutant mice associated with decreased
synchronous ﬁring of cortical neurons. However, evidence
for synaptic alterations has not been reported. Alteration of
developmental events may underlie the spontaneous seizures and
behavioral disorders observed in adult Caspr2 knockout mice
(Penagarikano et al., 2011).
Our data suggest a cell adhesive or cell-recognition function of
pre-synaptic Caspr2 interacting with TAG-1 at the post-synaptic
compartment. TAG-1 is the single interacting partner already
identiﬁed for Caspr2 ectodomain, and their cis-association has
been clearly evidenced (Poliak et al., 2003; Traka et al., 2003). We
showed here that pre-clustered Caspr2-Fc binds TAG-1 anchored
at the membrane of N2a cells indicating trans-interaction
between the two CAMs. In contrast, the reciprocal interaction is
not occurring between soluble TAG-1-Fc and Caspr2-expressed
at the cell membrane (Traka et al., 2003). Our recent data indicate
that the two molecules expressed at the membrane of opposing
cells can mediate trans-adhesive interaction as determined by
co-immunoprecipitation (Savvaki et al., 2010).
Both Caspr2 and TAG-1 are present in the fraction containing
synaptic plasma membranes (Bakkaloglu et al., 2008) with
Caspr2 highly depleted in the post-synaptic density fraction
(Chen et al., 2015). TAG-1 is faintly expressed at the surface
of cultured hippocampal neurons and detected at axon initial
segment (Ogawa et al., 2008) and it is also released as a soluble
form (Karagogeos et al., 1991). Strikingly, we observed that
Caspr2-Fc binds the somato-dendritic compartment of wild-type
but not of TAG-1-deﬁcient hippocampal neurons. We showed
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FIGURE 8 | TAG-1 is required for Caspr2-Fc binding on hippocampal
neurons. (A) N2a neuroblastoma cells were transfected with TAG-1-GFP
(green) and incubated with preclustered Caspr2-Fc (red). Caspr2-Fc only bound
on TAG-1-GFP expressing N2a cells. (B–G) DIV8 hippocampal neurons were
incubated with pre-clustered Caspr2-Fc (red) and cells were fixed and
permeabilized before immunostaining for MAP2 (blue). Wild-type neurons were
untransfected (B) or transfected with TAG-1-GFP (C), or double-transfected
with LGI1-GFP and ADAM22 (F) or LGI1-GFP and ADAM23 (G). Caspr2-Fc
strongly bound the TAG-1-GFP-expressing neuron (green) by comparison with
untransfected neurons (C). Transfection of LGI-GFP and ADAM22 or ADAM23
had no effect. (D,E) DIV8 hippocampal neurons from Tag-1−/− mice were
untransfected (D) or transfected with TAG-1-GFP (E). Caspr2-Fc strongly bound
the TAG-1-GFP-expressing neuron (green) and did not bind untransfected
Tag1−/− neurons. (H,H’) DIV14 hippocampal neurons were co-transfected with
TAG-1-GFP and mCherry. At DIV17, neurons were surface labeled with
anti-GFP antibodies, fixed, and permeabilized before immunostaining for
Synaptophysin (blue). Note that TAG-1-GFP clusters indicated with arrowheads
on the shaft (H) or spines (H’) were facing Synaptophysin presynaptic sites.
(A–G) Single confocal sections. (H,H’) z-stacks of four confocal sections with
z-step of 0.5 µm Bars: 10 µm, in (A–G), 4 µm in (H,H’).
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FIGURE 9 | Schematic representation of Caspr2 and Caspr2-Fc
complementary distribution in hippocampal neurons. (A) Anti-Caspr2
autoantibodies target preferentially the axons of inhibitory neurons. (B) TAG-1
is required as a post-synaptic receptor of Caspr2.
that Caspr2-Fc binding was strongly increased on TAG-1-
transfected neurons. LGI1 was also considered as a possible post-
synaptic receptor for Caspr2 as it is recruited within the VGKC
complex where it interacts with ADAM22 and ADAM23 (Ogawa
et al., 2008) and LGI1 is also involved in some autoimmune
encephalitis (Lai et al., 2010). However, we did not detect any
trans-interaction of Caspr2-Fc with any of these components.
We showed that both Caspr2-Fc binding sites and transfected
TAG-1-GFP were localized at post-synaptic sites on dendritic
shafts and spines facing synaptophysin-positive clusters. Thus,
taken together these data suggest that TAG-1 may be critically
involved as a post-synaptic partner of Caspr2. We observed
that half of excitatory post-synapses on spines were labeled with
Caspr2-Fc chimera, whereas Caspr2 was mainly expressed by
inhibitory neurons. Indeed, TAG-1 has been reported to interact
with several members of the L1 family (Felsenfeld et al., 1994;
Pavlou et al., 2002) and may interplay with other partners at the
excitatory synapse.
Caspr2 and LGI1 may be Differentially
Implicated in LE Autoimmunity
Both LGI1 and Caspr2 are targeted in some patients with
autoimmune LE (Irani et al., 2010; Lai et al., 2010). LGI1 is
also implicated in inherited forms of epilepsy (Morante-Redolat
et al., 2002). Like Caspr2, LGI1 is an element of the VGKC-
complex and may induce alteration of axonal excitability. LGI1
colocalizes at axonal terminals with Kv1.1 and Kv1.4 and is
strongly expressed on mossy ﬁbers in the hippocampus (Schulte
et al., 2006). Interestingly, anti-LGI1 autoantibodies of patients
with LE have been reported to induce epileptiform activity by
increasing the release probability on mossy ﬁbers-CA3 pyramidal
cell synapses, an eﬀect that is mimicked by antagonists of Kv1
channels (Lalic et al., 2010). Other works demonstrated that
LGI1 associated with ADAM22 is also implicated in regulating
synaptic transmission (Fukata et al., 2006) and that anti-LGI1
autoantibodies of patients with LE are able to neutralize LGI1-
ADAM22 interaction and to reduce synaptic clusters of AMPA
receptors in cultured hippocampal neurons (Ohkawa et al., 2013).
Since LGI1 is expressed by inhibitory interneurons as well as
excitatory neurons in hippocampus, epileptic activity may be
induced by function blocking of LGI1 on interneurons. However,
the selective deletion of Lgi1 in GABAergic parvalbumin neurons
does not induce spontaneous seizures or increased seizure
susceptibility. In contrast, depletion of LGI1 in pyramidal
neurons is suﬃcient to generate seizures suggesting that LGI1
plays a pathological role in speciﬁc neurons (Boillot et al.,
2014). Thus, it may be important to identify the subtypes of
neurons expressing Caspr2 to decipher the role of this CAM
in LE.
In the present study, we showed that Caspr2 is strongly
expressed by inhibitory neurons in hippocampal cell culture
including at their presynaptic terminals. Gephyrin is a main
constituent of the inhibitory post-synaptic densities that
anchors GABAA receptors. The dynamic exchange between
pools of extrasynaptic and synaptic Gephyrin is implicated
GABAAR stabilization and synaptic strength (Petrini et al.,
2014) and the clustering of Gephyrin can be aﬀected during
inhibitory synapse remodeling through CaMKII-dependent
phosphorylation (Flores et al., 2015). Our functional assays
using Gephyrin-GFP transfected hippocampal neurons indicated
that short-term incubation with anti-Caspr2 LE IgGs induced a
signiﬁcant decrease in the density of synaptic Gephyrin clusters.
However, the ratio of synaptic versus total Gephyrin-GFP
clusters was not modiﬁed. We hypothesize that autoantibodies
to Caspr2 may induce alterations of inhibitory synaptic contact
and Gephyrin clustering at the post-synapse. Because of
the dynamic exchange between the pools of synaptic and
total Gephyrin, the clustering of total Gephyrin may be also
perturbed. Thus our data suggest that Caspr2 autoantibodies
from LE patients might induce structural alteration of the
inhibitory post-synaptic scaﬀold by neutralizing Caspr2
function.
Selectivity of Anti-Caspr2 Autoantibodies in
the CSF and Serum of LE Patients
Autoantibodies have been reported to target selective modules
of CAMs in peripheral neuropathies. For example, CIDP
autoantibodies to Contactin are directed against functional
modules implicated in its interaction with its glial partner
Neurofascin155 and may thereby induce alteration of the
paranodal complex (Ng et al., 2012; Labasque et al., 2014).
Strikingly, in the present study, we showed that immunoreactivity
of anti-Caspr2 CSF IgGs was restricted to the N-terminal
discoïdin and LamininG1 domains in four out of seven
LE patients suggesting that these two domains may play a
major role in the physiopathology. The speciﬁc function of
these N-terminal modules is still unknown, but they contain
point mutations or deletions described in psychiatric, autism
spectrum and language disorders associated with the Caspr2
gene, cntnap2 (Zweier et al., 2009; O’Roak et al., 2011; Al-
Murrani et al., 2012). We may hypothesize that these domains
of Caspr2 could be implicated in its synaptic function. Indeed, we
showed that the LE6 IgGs that selectively target the N-terminal
modules display perturbing activity of the synaptic Gephyrin
clusters. We may also notice that the anti-Caspr2 serum IgGs
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of LE patients bound the juxtaparanodes of mouse sciatic
nerves whereas these patients did not present neuromyotonia.
This may be either due to the restricted accessibility of
juxtaparanodes or to the selectivity of the targeted N-terminal
epitopes.
Conclusion
This study highlights the role of inhibitory neurons as the
main target for anti-Caspr2 autoantibodies and the potential
role of the N-terminal discoïdin and LamininG1 domains. In
patients with LE, anti-Caspr2 autoantibodies may alter Gephyrin
clusters at inhibitory synaptic contacts possibly by disruption
of Caspr2/TAG-1 interactions. All these data provide a clue to
understand the central hyperexcitability observed in patients with
autoimmune LE.
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FIGURE S1 | Anti-Caspr2 IgGs of LE patients bind axons of hippocampal
neurons in culture. DIV7 hippocampal neurons were surface labeled with IgGs of
LE2 (A,B), LE3 (C,D), LE4 (E,F), LE5 (G,H) patients (red). Cells were fixed with 4%
paraformaldehyde, permeabilized and double-stained for the somato-dendritic
marker MAP2 (blue) or axonal tau (green). The LE IgGs did not bind hippocampal
neurons when pre-adsorbed using incubation with Caspr2-transfected HEK cells
(B,D,F,H). Surface staining for Caspr2 using LE2–LE5 IgGs was restricted to
tau-positive axons as indicated with yellow arrowheads in (A,C,E,G). Single optical
sections of confocal images. Bar is 7 µm.
FIGURE S2 | Anti-Caspr2 autoantibodies in LE patients label inhibitory
axons in hippocampal cell culture. Hippocampal neurons at DIV21 were
surface labeled with IgGs of LE2 (A), LE3 (B), LE4 (C), or LE5 (D) patients (red).
Cells were fixed and permeabilized before double-staining for MAP2 (blue) and
GAD65 (green). The overlay images and insets show that inhibitory axons and
pre-synaptic terminals were immunostained with all patient’s autoantibodies.
Single optical sections of confocal images. Bar is 10 µm; in insets, 3 µm.
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